Acorda Therapeutics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Acorda Therapeutics prevailing Real Value cannot be determined due to lack of data. The current price of Acorda Therapeutics is $0.0. Our model approximates the value of Acorda Therapeutics from analyzing the firm fundamentals such as Profit Margin of (2.15) %, return on equity of -0.24, and Current Valuation of 161.45 M as well as examining its technical indicators and probability of bankruptcy.
Acorda Therapeutics Total Value Analysis
Acorda Therapeutics is presently estimated to have valuation of 161.45 M with market capitalization of 821.03 K, debt of 190.9 M, and cash on hands of 20.7 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Acorda Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
161.45 M | 821.03 K | 190.9 M | 20.7 M |
Acorda Therapeutics Investor Information
About 13.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acorda Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.51. The entity recorded a loss per share of 203.57. The firm last dividend was issued on the 4th of January 2021. Acorda Therapeutics had 1:20 split on the 5th of June 2023. Based on the key indicators related to Acorda Therapeutics' liquidity, profitability, solvency, and operating efficiency, Acorda Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Acorda Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Acorda Therapeutics has an asset utilization ratio of 99.9 percent. This connotes that the Company is making $1.0 for each dollar of assets. An increasing asset utilization means that Acorda Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Acorda Therapeutics Ownership Allocation
Almost 86.09 percent of Acorda Therapeutics outstanding shares are held by general public with 0.69 (percent) owned by insiders and only 13.22 % by other corporate entities.Acorda Therapeutics Profitability Analysis
The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M.Acorda Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Acorda Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 M | |
| Quarterly Earnings Growth Y O Y | 5.873 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |